Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-333014

See Remarks sold 12,415 shares at $10.05 ($124,722)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kirn David See Remarks 2026-08-03 Sale 10b5-1 −12,415 $10.05 $124,722 871,737 D: show line 1 in the form
Open-market sales · 12,415 sh · avg $10.05 · $124,722
Loading xslF345X06/ownership.xml…